Рет қаралды 10,763
In this must-watch video, chronic lymphocytic leukemia doctors and patient advocates share the LATEST treatment options that are revolutionizing care. Learn how new targeted therapies and clinical trials are dramatically improving QUALITY OF LIFE and outcomes for CLL patients.
Hear first-hand from Jeff Folloder, a 14-year CLL survivor and Michele Nadeem-Baker, a patient advocate diagnosed with CLL 11 years ago. They're joined by Dr. Catherine Coombs with UCI Health and Dr. M. Yair Levy with Texas Oncology.
Other key topics covered include:
➡️ The evolving landscape of CLL treatments, including BTK inhibitors like ibrutinib, venetoclax, and combination therapies
➡️ Shared decision making between patients and doctors to determine the best treatment plan
➡️ When to start treatment versus watch and wait approaches
➡️ How newer therapies allow for fixed duration treatment versus indefinite treatment
➡️ The importance of clinical trials in developing new CLL treatments
Full story & transcript → thepatientstory.com/patient-p...
✉️ Stay connected: Sign up for our newsletter to receive more inspiring patient stories, the latest medical updates and personalized advice: www.thepatientstory.com/newsl...
Join Our Community:
Website : www.thepatientstory.com/
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story
Contents of this video:
3:45 - The Evolving landscape of CLL Treatments
11:05 - Watch & Wait: When to get treatment
16:42 - Planning Treatment
20:38 - Adding a monoclonal antibody to treatment
28:45 - Clinical Trials
32:24 - Guidance to patients/caregivers
#thepatientstory #cllsm #sll #chroniclymphocyticleukemia #leukemia #patientstories #cancerstories #cancerpatient #cancersurvivor #bloodcancer #CLL #CLLawareness #CLLresearch #CLLtreatment #CLLsupport #CLLclinicaltrials #livingwithCLL
#CLLchemo #CLLwatchandwait